These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10528783)

  • 41. Demonstration of in vitro antagonism between fusidic acid and quinolones.
    Ertek M; Yazgi H; Erol S; Altoparlak U
    J Int Med Res; 2002; 30(5):525-8. PubMed ID: 12449523
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fatal bacteraemia and infective endocarditis due to meticillin-resistant Staphylococcus aureus (MRSA) with rapid emergence of rifampicin resistance during vancomycin/rifampicin combination treatment.
    Liu WL; Hung YL; Lin SH; Lee PI; Hsueh PR
    Int J Antimicrob Agents; 2010 Jun; 35(6):615-6. PubMed ID: 20236804
    [No Abstract]   [Full Text] [Related]  

  • 43. Antimicrobial salvage therapy for native valve MRSA endocarditis.
    Cortes J; Sagar AS; Lee Y; Sandhu U; Boka K
    J Antimicrob Chemother; 2017 Jun; 72(6):1841-1842. PubMed ID: 28333236
    [No Abstract]   [Full Text] [Related]  

  • 44. Successful Use of High-dose Daptomycin in a Child With Staphylococcus aureus Endocarditis.
    Prabhudesai S; Kanjani A; Nambi PS; Gnanasambandam S; Ramachandran B
    Pediatr Infect Dis J; 2016 May; 35(5):517-8. PubMed ID: 27074655
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Failure of combination therapy for Staphylococcus aureus bone infection: a case of in vivo selection with resistance to rifampicin and fusidic acid.
    Aubin GG; Bémer P; Guillouzouic A; Launay E; Geffroy L; Touchais S; Corvec S
    Infect Dis (Lond); 2016 Sep; 48(9):699-702. PubMed ID: 27194514
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients.
    Lin JC; Aung G; Thomas A; Jahng M; Johns S; Fierer J
    J Infect Chemother; 2013 Feb; 19(1):42-9. PubMed ID: 22797874
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New agents for Staphylococcus aureus endocarditis.
    Drees M; Boucher H
    Curr Opin Infect Dis; 2006 Dec; 19(6):544-50. PubMed ID: 17075329
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Resistance to fusidic acid.
    Turnidge J; Collignon P
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S35-44. PubMed ID: 10528785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Staphylococcal bacteremia and endocarditis: state of the art.
    Bayer AS
    Arch Intern Med; 1982 Jun; 142(6):1169-77. PubMed ID: 6807232
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Severe infections caused by methicillin-resistant Staphylococcus aureus. 62 cases].
    May T; Janbon F; Beuscart C; Meyran M; Roue R
    Presse Med; 1993 May; 22(19):909-13. PubMed ID: 8378281
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neutrophil-targeted combinatorial nanosystems for suppressing bacteremia-associated hyperinflammation and MRSA infection to improve survival rates.
    Chang YT; Lin CY; Chen CJ; Hwang E; Alshetaili A; Yu HP; Fang JY
    Acta Biomater; 2024 Jan; 174():331-344. PubMed ID: 38061677
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Successful treatment of disseminated methicillin-resistant Staphylococcus aureus with fosfomycin, cefoperazone/sulbactam and rifampin followed by fusidic acid and rifampin.
    Apisarnthanarak A; Mundy LM
    Int J Infect Dis; 2007 May; 11(3):283-4. PubMed ID: 16876452
    [No Abstract]   [Full Text] [Related]  

  • 53. Staphylococcus aureus bacteremia and endocarditis. New diagnostic and therapeutic concepts.
    Mortara LA; Bayer AS
    Infect Dis Clin North Am; 1993 Mar; 7(1):53-68. PubMed ID: 8463653
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Antibiotherapy of infectious endocarditis].
    Meyssonnier V; Bricaire F
    Rev Prat; 2012 Apr; 62(4):522-7. PubMed ID: 22641896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Executive summary of the diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC).
    Gudiol F; Aguado JM; Almirante B; Bouza E; Cercenado E; Domínguez MÁ; Gasch O; Lora-Tamayo J; Miró JM; Palomar M; Pascual A; Pericas JM; Pujol M; Rodríguez-Baño J; Shaw E; Soriano A; Vallés J
    Enferm Infecc Microbiol Clin; 2015 Nov; 33(9):626-32. PubMed ID: 25937456
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treatment of MRSA infections].
    Borde JP; Kern WV
    Dtsch Med Wochenschr; 2012 Dec; 137(49):2553-7. PubMed ID: 23143638
    [No Abstract]   [Full Text] [Related]  

  • 57. Staphylococcus aureus bacteremia: using echocardiography to guide length of therapy.
    Kim AI; Adal KA; Schmitt SK
    Cleve Clin J Med; 2003 Jun; 70(6):517, 520-1, 525-6 passim. PubMed ID: 12828223
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increasing rate of detection of fusidic acid resistance in methicillin-resistant Staphylococcus aureus isolated from clinical samples in Malaysia.
    Alreshidi MA; Mariana NS
    Med J Malaysia; 2011 Aug; 66(3):276. PubMed ID: 22111461
    [No Abstract]   [Full Text] [Related]  

  • 59. Fusidic acid in skin and soft tissue infections.
    Spelman D
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S59-66. PubMed ID: 10528787
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Case report: treatment of chronic osteomyelitis.
    Wolfe CR
    Clin Infect Dis; 2011 Jun; 52 Suppl 7():S538-41. PubMed ID: 21546631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.